TSO3 announces the results of the vote for the election of the members of the Board of Directors

Ticker:  TSX – TOS 
Shares Outstanding: 73,000,906

QUÉBEC CITY, May 8, 2014 /CNW Telbec/ - TSO₃ Inc. (TSX: TOS) ("TSO₃" or the "Corporation") an innovator in low temperature sterilization technology for medical devices in healthcare settings, announced that the nominees listed in the management proxy circular dated March 18, 2014, were elected as directors of TSO₃ Inc.

­Election of Directors

The shareholders were asked to provide their decision via a vote by proxy as part of TSO₃ Annual General Meeting of Shareholders, held on May 7, 2014 in Québec.  The detailed results of the vote are set out below.

Name of Nominee	Votes for	% for	Votes against	% against	Withheld/ Abstain	% withheld
Germain Carrière	30,431,123	98.83	0	0	361,362	1.17
Pierre Désy	30,429,823	98.82	0	0	362,662	1.18
James R. Husman	26,248,918	85.24	0	0	4,543,567	14.76
Jean Lamarre	26,240,998	85.22	0	0	4,551,487	14.78
W. Barry McDonald	30,421,743	98.80	0	0	370,742	1.20
Claude Michaud	30,438,223	98.85	0	0	354,262	1.15
Richard M. Rumble	30,396,243	98.71	0	0	296,242	1.29
Independent Auditors	24,689,185	77.68	0	0	7,093,803	22.32

Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 7, 2014, will be filed on SEDAR (www.sedar.com) under the name TSO₃.

About TSO₃

TSO₃, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential. TSO₃ designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solutions to other low temperature sterilization processes currently used in hospitals. For more information about TSO₃, visit the Company's Web site at www.tso3.com.

The statements in this release and oral statements made by representatives of TSO₃ relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO₃) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO₃ to obtain financing on favourable terms and other risks and uncertainties.

The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.

SOURCE: TSO3 Inc.

R.M. (Ric) Rumble, President and CEO, [phone], Ext. 254, Email: [email protected]